Aries Wealth Management Eli Lilly & CO Transaction History

Aries Wealth Management

$359 Million
Q3 2024

A detailed history of Aries Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Aries Wealth Management holds 4,186 shares of LLY stock, worth $3.16 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

4,186

Previous 3,288 27.31%

Holding current value

$3.16 Million

Previous $2.98 Million 24.6%

% of portfolio

1.03%

Previous 0.94%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$772.14 - $960.02 $693,381 - $862,097	898 Added 27.31%	4,186 $3.71 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $85,869 - $114,880	-145 Reduced 4.22%	3,288 $2.56 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $27,309 - $32,194	-52 Reduced 1.49%	3,433 $2 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $96,503 - $133,044	-222 Reduced 5.99%	3,485 $1.87 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $2,104 - $2,813	6 Added 0.16%	3,707 $1.74 Million
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $8,697 - $10,214	28 Added 0.76%	3,701 $1.27 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $9,646 - $11,240	30 Added 0.82%	3,673 $0
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $19,864 - $22,637	67 Added 1.87%	3,643 $1.32 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $996,738 - $1.17 Million	3,576 New	3,576 $1.16 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $768,140 - $954,603	-3,273 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$224.85 - $279.04 $4.42 Million - $5.48 Million	-19,638 Reduced 85.71%	3,273 $904,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $4.45 Million - $5.52 Million	19,796 Added 635.51%	22,911 $6.33 Million
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $44,763 - $55,087	202 Added 6.93%	3,115 $720,000
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $51,095 - $66,091	283 Added 10.76%	2,913 $669,000
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $115,024 - $148,904	700 Added 36.27%	2,630 $481,000
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $18,711 - $23,175	-175 Reduced 8.31%	1,930 $255,000
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $34,706 - $37,752	-325 Reduced 13.37%	2,105 $228,000
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $13,767 - $15,423	-130 Reduced 5.08%	2,430 $281,000
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $209,766 - $224,998	2,560	2,560 $219,000

Others Institutions Holding LLY

# of Institutions

4,029

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.

Account

Aries Wealth Management Eli Lilly & CO Transaction History